SYSTEMATIC REVIEW RASIONALITAS ANTIHIPERTENSI PADA PREEKLAMSIA DI BEBERAPA RUMAH SAKIT DI INDONESIA MENGGUNAKAN PENDEKATAN PRISMA
Abstract
Globally, preeclampsia is one of the main contributors to maternal mortality. In Indonesia, discrepancies between clinical practice and guideline recommendations for antihypertensive use in preeclampsia cases remain relatively high, potentially increasing risks for both mothers and fetuses. This study is a PRISMA-based systematic review that aims to evaluate the rational use of antihypertensive drugs in preeclampsia patients across various hospitals in Indonesia. A literature search was conducted in PubMed and Google Scholar for the period 2015–2025, identifying 76 articles, of which 11 met the inclusion and exclusion criteria. Most studies assessed three parameters of rationality—appropriate drug, appropriate indication, and appropriate dose—with mean adherence rates of 92.55%, 91.69%, and 86.73%, respectively. Nifedipine was the most commonly used first-line agent, while methyldopa was frequently used as an alternative or in combination; however, several hospitals still reported the use of drugs that are not recommended, such as candesartan. Variations in practice were mainly related to limited availability of first-line drugs and inconsistent implementation of dosing protocols, as reflected by one hospital where dose appropriateness reached only 5.3%. Overall, the use of antihypertensive therapy for preeclampsia in Indonesia is generally in line with existing guidelines; nevertheless, equitable access to essential medicines and ongoing training for healthcare workers are still needed to address therapy discrepancies arising from resource limitations.References
Azzahra, I.E., Choesrina, R. and Yuniarni, U. (2024) ‘Evaluation Of the Use of Antihypertensive Drugs in Inpatient Preeclampsia Patients in the Lembang Regional Hospital’, Jurnal Ilmiah Farmasi Farmasyifa, 7(2), pp. 158–168. Available at: https://doi.org/10.29313/jiff.v7i2.3676.
Cresswell, J.A. et al. (2025) ‘Global and regional causes of maternal deaths 2009-20: a WHO systematic analysis.’, The Lancet. Global health, pp. 626–634. Available at: https://doi.org/10.1016/S2214-109X(24)00560-6.
Easterling, T. et al. (2019) ‘Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial’, The Lancet, 394(10203), pp. 1011–1021. Available at: https://doi.org/10.1016/S0140-6736(19)31282-6.
Fahrezy, A.I. and Fadillah, A. (2025) ‘Rasionalitas Penggunaan Obat Antihipertensi Pada Pasien Preeklampsia Rawat Inap Di RSUD Muara Teweh Periode Tahun 2023’, Jurnal Kesehatan Tambusai, 6, pp. 353–359. Available at: https://doi.org/https://doi.org/10.31004/jkt.v6i1.38192.
Kristiyowati, A.D., Sayyidah and Kuswara, S. (2024) ‘Evaluasi Rasionalitas Penggunaan Obat Antihipertensi Pada Ibu Hamil Dengan Preeklampsia Di Instalasi Rawat Inap Di RSU Kota Tangerang Selatan’, Prosiding SEMLITMAS: Diseminasi Penelitian Pengabdian Masyarakat, 1(1), pp. 319–329.
Kurniawati, D., Septiyono, E. and Sari, R. (2020) Preeklampsia dan Perawatannya Untuk Ibu Hamil, Keluarga, Kader maupun Khalayak Umum. Edited by Jauhari. Jember: KHD Production.
Lintang, B.; H. (2021) ‘Studi Penggunaan Obat Anti Hipertensi Pada Pasien Preeklamsia Di Instalasi Rawat Inap Rs Aura Syifa Kediri’, Java Health Journal, 2.
Madania, M. et al. (2024) ‘Studi Penatalaksanaan dan Ketepatan Pengobatan Antihipertensi pada Wanita Hamil di RSUD Toto Kabila’, Journal Syifa Sciences and Clinical Research, 6(1), pp. 34–45. Available at: https://doi.org/10.37311/jsscr.v6i1.23785.
Maisarah et al. (2020) ‘Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Ibu Hamil Dengan Preeklampsia Di Rsud Abdul Wahab Sjahrani Samarinda Periode Januari-Desember 2020’, Prosiding Seminar Nasional Kesehatan, 1(1), pp. 19–28.
Oktarina, O. et al. (2024) ‘Risk factors for hypertension in pregnant women in Indonesia: A cross-sectional study’, Asian Pacific Journal of Tropical Medicine, 17(9), pp. 408–417. Available at: https://doi.org/10.4103/apjtm.apjtm_832_23.
Pratiwi, R., Indriyani, I. and Tetra Putra, R. (2024) ‘Innovation in Health for Society Trends in the initial management of severe preeclampsia and eclampsia in Indonesia : A medical record study ( 2018 – 2021 )’, 4(222), pp. 101–109.
Saputri, G.A.R., Ulfa, A.M. and Jannah, M. (2021) ‘Evaluasi Rasionalitas Penggunaan Obat Antihipertensi Pada Pasien Preeklampsia Rawat Inap Di Rsud Jend. Ahmad Yani Metro Periode Tahun 2019’, Jurnal Farmasi Malahayati, 3(2), pp. 137–147. Available at: https://doi.org/10.33024/jfm.v3i2.3424.
Simatupang, A. and Dwipajaya, I.B.S. (2021) ‘Evaluation of administration and use of antihypertensive drugs in severe preeclampsia patients at X General Hospital in Jakarta’, Indonesian Journal of Pharmacology and Therapy, 2(2), pp. 85–91. Available at: https://doi.org/10.22146/ijpther.1347.
Singhal, S. and Gupta, A. (2015) ‘A comparative randomized controlled parallel group study of efficacy and tolerability of labetalol versus methyldopa in the treatment of mild preeclampsia’, International Journal of Basic and Clinical Pharmacology, 4(3), pp. 442–445. Available at: https://doi.org/10.18203/2319-2003.ijbcp20150011.
Sutrisno, E. et al. (2024) ‘Evaluation of antihypertensive drug use in preeclampsia and eclampsia patients in the inpatient room of Bandung Regency Hospital’, 12(4).
Wijaya, D. et al. (2023) ‘A Rationality Study of Antihypertensive Drugs Usage in Preeclampsia Patients in the Private Hospital’, Proceedings of International Pharmacy Ulul Albab Conference and Seminar (PLANAR), 3, p. 37. Available at: https://doi.org/10.18860/planar.v3i0.2470.
World Health Organization (2023) Maternal Mortality, Maternal Mortality. Available at: https://www.who.int/news-room/fact-sheets/detail/maternal-mortality (Accessed: 4 April 2025).
World Health Organization (2024) Pre-eclampsia, Pre-eclampsia. Available at: https://www.who.int/news-room/fact-sheets/detail/pre-eclampsia?utm.com (Accessed: 10 April 2025).
Yani, Y.A. et al. (2021) ‘Evaluasi Penggunaan Obat Antihipertensi Pasien Preeklampsia di Instalasi Rawat Inap RSUD Prof. Dr. W.z Johannes Kupang’, CHMK Pharmaceutical Scientific Journal, 4(1), pp. 242–248.
Yin, J. et al. (2022) ‘Nifedipine or amlodipine? The choice for hypertension during pregnancy: a systematic review and meta-analysis’, Archives of Gynecology and Obstetrics, 306(6), pp. 1891–1900. Available at: https://doi.org/10.1007/s00404-022-06504-5.
